Olfr607, a member of the olfactory receptor family, plays a pivotal role in the intricate process of olfactory signal transduction within the sensory epithelium. As a G protein-coupled receptor (GPCR), Olfr607 is instrumental in recognizing and transducing signals from specific odorant molecules, initiating downstream events that lead to the perception of olfactory stimuli. Functionally, Olfr607 engages in diverse intracellular pathways, with notable involvement in mitochondrial complex I, mTOR, SIRT1, glycolysis, and various other cellular processes. The inhibition of Olfr607 encompasses a spectrum of chemicals that act through both direct and indirect mechanisms. Methylene Blue, for instance, serves as an indirect inhibitor by influencing the NADH/NAD+ ratio, leading to downstream alterations that negatively regulate Olfr607 expression. Additionally, Tanespimycin acts as a direct inhibitor by targeting HSP90, disrupting downstream chaperone activities and negatively impacting Olfr607 function within the cellular context. These inhibitors collectively underscore the complex regulatory network governing Olfr607 activity and provide insights into potential strategies for modulating olfactory perception.
Indirect inhibitors, such as Resveratrol and 2-Deoxyglucose, modulate SIRT1 and glycolysis, respectively, altering downstream events that negatively regulate Olfr607 expression and function. Specific interference with the TGF-β/Smad pathway by SB-431542 and lysosomal acidification by Bafilomycin A1 showcases the interconnected nature of olfactory signal transduction pathways. The diverse mechanisms of inhibition highlight the multifaceted nature of olfactory receptor regulation, opening avenues for further exploration into the molecular intricacies of olfactory perception. In summary, Olfr607 serves as a molecular mediator in olfactory signal transduction, with its inhibition governed by a range of chemicals influencing key cellular pathways associated with its function. The interplay between these inhibitors and the intricate pathways associated with Olfr607 underscores the complexity of olfactory receptor regulation, providing valuable insights into potential strategies for modulating olfactory perception.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $42.00 $102.00 $322.00 | 3 | |
Methylene Blue serves as an indirect inhibitor by influencing the NADH/NAD+ ratio. Its impact on cellular redox balance leads to downstream alterations that negatively regulate Olfr607 expression. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Rotenone acts as an indirect inhibitor by targeting mitochondrial complex I. Inhibition of complex I disrupts mitochondrial function, leading to downstream events that negatively impact Olfr607 activity. | ||||||
KU 0063794 | 938440-64-3 | sc-361219 | 10 mg | $209.00 | ||
Ku-0063794 inhibits Olfr607 through specific interference with the mTOR pathway. Its action on mTOR disrupts downstream signaling cascades, negatively affecting Olfr607 function within cellular contexts. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol serves as an indirect inhibitor through modulation of the SIRT1 pathway. By activating SIRT1, it influences downstream events that negatively regulate Olfr607 expression and function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxy-D-glucose acts as an indirect inhibitor by targeting glycolysis. Inhibition of glycolysis alters cellular metabolism, leading to downstream effects that negatively regulate Olfr607 activity. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
Tanespimycin serves as a direct inhibitor by targeting HSP90. Inhibition of HSP90 disrupts downstream chaperone activities, negatively impacting Olfr607 function within the cellular context. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $118.00 $287.00 | 36 | |
Pifithrin-α(HBr) inhibits Olfr607 by targeting p53. Its inhibitory effect on p53 disrupts downstream signaling events, negatively impacting Olfr607 activity within cellular contexts. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB-431542 serves as an indirect inhibitor by interfering with the TGF-β/Smad pathway. Its action on Smad disrupts downstream signaling cascades, negatively affecting Olfr607 function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits Olfr607 through specific interference with the lysosomal acidification process. The disrupted lysosomal function negatively affects Olfr607 signaling and cellular impact. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 serves as an indirect inhibitor by targeting PI3K. Its interference with PI3K disrupts downstream Akt signaling, negatively impacting Olfr607 function within the cellular environment. |